SIETES :: 93213 citas

Resultados de la búsqueda por LINFOMA CUTÁNEO DE CÉLULAS T

1.

Anónimo. Tacrolimus dermique: cancers (suite). Prescrire 2012;32:361. [Ref.ID 92812]

2.

Anónimo. Tacrolimus ointment (Protopic): reminder of a possible risk of malignancies including lymphomas and skin cancers. Drug Safety Update 2012;5:junio. [Ref.ID 92647]

3.

Anónimo. Tacrolimus topique: cancers (suite). Prescrire 2008;28:828. [Ref.ID 84369]

4.

Anónimo. Denileukin diftitox. Label to include reports of visual loss. USA. WHO Pharmaceuticals Newsletter 2006;3:1. [Ref.ID 77495]

5.

Miselli M, Zanfi D. Bexarotene. Informazioni sui Farmaci 2004;28:99-100. [Ref.ID 71662]

6.

Anónimo. Bexarotène: lymphomes cutanés: trop d'effets indésirables. Prescrire 2003;23:816-20. [Ref.ID 68566]

7.

Anónimo. Three more EU orphan designations. Scrip 2003;2861:4. [Ref.ID 66209]

8.

Finsterer J. Earl Grey tea intoxication. Lancet 2002;359:1484. [Ref.ID 61518]

9.

Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS, Jorgensen JL, Fich CJ, Butel JS. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002;359:817-32. [Ref.ID 61164]

10.

Malkin D. Simian virus 40 and non-Hodgkin lymphoma. Lancet 2002;359:812-3. [Ref.ID 61161]

11.

Anónimo. Drugs of choice for cancer chemotherapy. Med Lett Drugs Ther 2000;42:83-92. [Ref.ID 52816]

12.

Anónimo. Bexarotene (Targretin) for cutaneous T-cell lymphoma. Med Lett Drugs Ther 2000;42:31-2. [Ref.ID 50780]

13.

Henney JE. New drug for refractory cutaneous T-cell lymphoma. JAMA 2000;283:1131. [Ref.ID 49669]

14.

Regan F A M, Hewitt P, Barbara JAJ, Contreras M, on behalf of the current TTI Study Group. Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. BMJ 2000;320:403-6. [Ref.ID 49408]

15.

Anónimo. FDA panel endorses Ligand's Targretin. Scrip 1999;2499:21. [Ref.ID 48206]

16.

Anónimo. Interferon alpha-2a. Prescrire Int 1994;3:68-70. [Ref.ID 21802]